Chimeric antigen receptor (CAR) T-cell therapy boosts survival rates for relapsed and refractory cancer patients.
Penn State Health is first in the region to employ the da Vinci SP to offer improved outcomes for patients with head and neck cancers.
The children’s hospital treats patients with congenital heart disease for both the heart defect and any sequelae of their condition.
Providers at Penn State Health Children’s Hospital constantly innovate to treat pediatric congenital heart disease (CHD). The multidisciplinary care provided at the Complex Fetal Care Center complements their work.
Providers in the Pediatric Cardiac Intensive Care Unit at Penn State Health Children’s Hospital deliver postoperative care to the patient while also preparing families to transition to care at home.
Researchers at Penn State Health Milton S. Hershey Medical Center confirm the correlation between stroke, epilepsy and dementia and seek to improve patient outcomes through appropriate treatment and monitoring.
While advancing technology is revolutionizing care for epilepsy, a team approach that treats all facets of life touched by the disease also makes a profound difference for patients.
Penn State Health Milton S. Hershey Medical Center offers advanced care and access to clinical research for MS patients.
Specialists at Penn State Health Milton S. Hershey Medical Center are dedicated to helping adult and pediatric patients with neurofibromatosis maintain function and achieve a high quality of life while proactively detecting and managing complications.
As reflected in their superior patient outcomes — including a nearly 100% survival rate following heart transplant — Penn State Health Milton S. Hershey Medical Center’s Heart and Vascular physicians set the bar high for cardiac and vascular care.
Lung cancer is still the leading cause of cancer-related deaths, claiming the lives of an estimated 135,720 Americans in 2020. Penn State Health St. Joseph Cancer Center is striving to improve lung cancer patient outcomes by following guidelines for screening, offering advanced treatments and taking a multidisciplinary approach to each patient — all while giving hope to patients with lung cancer in the community.
Penn State Health now offers advanced treatment for thyroid nodules.
Surgeons can now see a rare cancer with greater precision, leading to more complete surgical removal.
Penn State Health Milton S. Hershey Medical Center offers patients who are not candidates for gallbladder removal the opportunity to live life drain-free through percutaneous endoscopic biliary lithectomy (PEBL).
Penn State Health is using imaging technology that combines multiple image types to diagnose prostate cancer more precisely and render surgical treatment less invasive and more effective. The technology has significant implications for improving patient quality of life.
At Penn State Cancer Institute, the increased adoption of active surveillance for prostate cancer patients is yielding positive outcomes while deferring or eliminating the negative side effects of treatment.
Penn State Health Milton S. Hershey Medical Center is improving postoperative outcomes for urologic surgery patients.
Penn State Health Children’s Hospital has been repeatedly distinguished as one of the leading hospitals in the nation for superior survival rates among pediatric heart surgery patients.
The Gender Health Clinic at Penn State Health Children’s Hospital provides care to children and young adults questioning their gender identity.
From research and innovation to comprehensive reproductive health care and bundled pricing, the Division of Reproductive Endocrinology and Infertility (REI) with Penn State Health Milton S. Hershey Medical Center is improving access to high-quality care while containing treatment costs.